| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/18/2000 | DE19852826A1 Poly(alpha-1,4-D-Glucan) Poly (alpha-1,4-D-glucan) |
| 05/18/2000 | DE19852508A1 Use of fat-soluble substance obtained from avocado oil as an antiphlogistic, antirheumatic, antimycotic or antiscabiotic agent, or as a toothpaste, lipstick, leather treatment agent or in bandages |
| 05/18/2000 | DE19852192A1 Wirkstoffhaltige aromatische Copolyester Active ingredient-containing aromatic copolyester |
| 05/18/2000 | DE19830770C1 Wasserlösliche Zinkpyruvate bzw. deren Hydrate, Verfahren zu ihrer Herstellung und deren Verwendung Water-soluble zinc pyruvate or hydrates thereof, processes for their preparation and their use |
| 05/18/2000 | CA2351222A1 Vancoresmycin, a process for its production and its use as a pharmaceutical |
| 05/18/2000 | CA2351145A1 Vaccine against papillomatous digital dermatitis (pdd) |
| 05/18/2000 | CA2351063A1 A system for administering a bioactive agent by inhalation comprising a lipid mixture comprising phosphatidylcholine |
| 05/18/2000 | CA2351017A1 Catfiiia candida albicans tfiiia gene (catfiiia) and the coded catfiiia protein |
| 05/18/2000 | CA2350771A1 Chemokine .beta.-7 |
| 05/18/2000 | CA2350429A1 Neurotrophic diamide and carbamate agents |
| 05/18/2000 | CA2350183A1 Use of an enterobacterium protein ompa for specific targeting towards antigen-presenting cells |
| 05/18/2000 | CA2349679A1 Modified exosomes and uses |
| 05/18/2000 | CA2349592A1 Use of gm-csf to inhibit development of drug resistance in hiv+ patients |
| 05/18/2000 | CA2349498A1 Methods and compositions for treating or preventing peripheral neuropathies |
| 05/18/2000 | CA2348946A1 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 05/18/2000 | CA2348699A1 Virulence genes and proteins, and their use |
| 05/18/2000 | CA2348382A1 Chimeric parvovirus vectors and methods of making and administering the same |
| 05/18/2000 | CA2348308A1 Rantes-derived peptides with anti-hiv activity |
| 05/17/2000 | EP1001032A2 Recombinant retroviruses delivering vector constructs to target cells |
| 05/17/2000 | EP1001030A1 Recombinant CELO virus and CELO virus DNA |
| 05/17/2000 | EP1001025A2 Outer membrane proteins from actinobacillus pleuropneumoniae |
| 05/17/2000 | EP1000952A2 New 2-halogenated derivatives of 5-O-deosaminylerythronolide A, process for making them as well as their use as medicines |
| 05/17/2000 | EP1000945A1 PROCESS FOR PRODUCING $g(b)-LACTAM DERIVATIVES |
| 05/17/2000 | EP1000628A1 Use of antigenic complexes of HIV envelope and HLA class I antigens as HIV vaccine |
| 05/17/2000 | EP1000625A1 Antibacterial composition |
| 05/17/2000 | EP1000622A2 Antiviral agents |
| 05/17/2000 | EP1000542A1 Antimicrobial composition and its use, especially in cosmetics and dermatology |
| 05/17/2000 | EP1000163A1 $i(PSEUDOMONAS) EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS |
| 05/17/2000 | EP1000157A1 Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy |
| 05/17/2000 | EP1000153A2 Crustacean antimicrobial peptides |
| 05/17/2000 | EP1000144A2 Lactoferrin receptor genes of moraxella |
| 05/17/2000 | EP1000086A1 Alatrofloxacin parenteral compositions |
| 05/17/2000 | EP1000080A1 Lyxofuranosyl benzimidazoles as antiviral agents |
| 05/17/2000 | EP1000029A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| 05/17/2000 | EP1000024A1 Mercaptoacylamino acids as metallo-beta-lactamase inhibitors |
| 05/17/2000 | EP0999856A2 Radiopharmaceuticals for imaging infection and inflammation |
| 05/17/2000 | EP0999854A1 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 05/17/2000 | EP0999852A1 Oil in water vaccine compositions |
| 05/17/2000 | EP0999851A1 Use of an enzyme for the manufacture of an agent for controlling bacterial infection |
| 05/17/2000 | EP0999850A2 Methods and compositions for regulating nuclear trafficking of proteins |
| 05/17/2000 | EP0999849A1 Therapeutic agent for the treatment of septicaemia, its preparation and use |
| 05/17/2000 | EP0999842A1 Novel substituted imidazole compounds |
| 05/17/2000 | EP0999838A1 Self-emulsifying formulation for lipophilic compounds |
| 05/17/2000 | EP0999826A1 Self-emulsifying formulation for lipophilic compounds |
| 05/17/2000 | EP0773950A4 Linked peptide nucleic acids |
| 05/17/2000 | EP0605700B1 Flavopereirine-based pharmaceutical composition and use thereof for treating hiv |
| 05/17/2000 | CN1253590A Bacterial plasmids |
| 05/17/2000 | CN1253548A HIV protease inhibitors |
| 05/17/2000 | CN1253506A Chimeric flavirirus vaccines |
| 05/17/2000 | CN1253504A Cytokine related treatments of disease |
| 05/17/2000 | CN1253176A Composition and method for protecting animals from diseases related with slow action virus |
| 05/17/2000 | CN1253019A Method for preparing medicine composition capable of inhibiting post infective virus proteinase |
| 05/17/2000 | CN1253014A Chinese-medicinal decoction for treating lung diseases |
| 05/17/2000 | CN1052510C Mammalian receptors for interleukin-10 |
| 05/16/2000 | US6063918 Reacting a base with a 2-azetidinyl-3,4-dihalogeno-2-butenoic acid compound in an aqueous organic solvent to yield a cyclized isooxacephalosporin derivative; simplification |
| 05/16/2000 | US6063801 Heterocyclic topoisomerase poisons |
| 05/16/2000 | US6063797 γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor |
| 05/16/2000 | US6063795 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/16/2000 | US6063790 Diarylsulfone non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus |
| 05/16/2000 | US6063778 Cephalosporin derivatives and processes for the preparation thereof |
| 05/16/2000 | US6063769 1-thiogalactose derivatives |
| 05/16/2000 | US6063760 Proteins with amino acid sequences |
| 05/16/2000 | US6063628 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA |
| 05/16/2000 | US6063394 Injection formulations of avermectins and milbemycins based on castor oil |
| 05/16/2000 | US6063386 Recombinant multivalent M protein vaccine |
| 05/16/2000 | US6063376 Human deoxycytidine kinase 2 |
| 05/16/2000 | CA2215020C Tetrazolyl-substituted quinuclidines as substance p antagonists |
| 05/16/2000 | CA2191920C Derivatives of 3-deoxy 16-membered ring macrolide antibiotics |
| 05/16/2000 | CA2018794C Crystalline cephem acid addition salts and processes for their preparation |
| 05/16/2000 | CA2013226C Cephalosporin derivatives and processes for their preparation |
| 05/11/2000 | WO2000026399A2 Method for the production of quercetin and isoquercetin derivatives |
| 05/11/2000 | WO2000026395A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 05/11/2000 | WO2000026385A1 Nucleic acid constructs for genetic immunization |
| 05/11/2000 | WO2000026380A1 Rotavirus subunit vaccine |
| 05/11/2000 | WO2000026376A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026347A1 Methods for the production of tcr gamma delta t cells |
| 05/11/2000 | WO2000026245A2 Human membrane transport proteins |
| 05/11/2000 | WO2000026243A2 Transmembrane 4 proteins |
| 05/11/2000 | WO2000026240A2 Streptococcal alpha2m-binding protein |
| 05/11/2000 | WO2000026239A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026237A2 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 05/11/2000 | WO2000026225A2 Nucleosides with anti-hepatitis b virus activity |
| 05/11/2000 | WO2000026224A2 Novel macrolide antibiotics |
| 05/11/2000 | WO2000026216A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 05/11/2000 | WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity |
| 05/11/2000 | WO2000026206A1 Method for producing luteolin and luteolin derivatives |
| 05/11/2000 | WO2000026203A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/11/2000 | WO2000026202A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/11/2000 | WO2000026201A1 Benzoylpyridazines |
| 05/11/2000 | WO2000026197A1 Novel inhibitors of impdh enzyme |
| 05/11/2000 | WO2000026167A1 Vitamin d analogues |
| 05/11/2000 | WO2000025908A1 Method for preparing capsules consisting of a liquid active material core enclosed in a mineral coating |
| 05/11/2000 | WO2000025818A1 asuE/trmU |
| 05/11/2000 | WO2000025816A1 Treatment of hepatitis c by administration of anti-il-2 receptor monoclonal antibody and an antiviral compound |
| 05/11/2000 | WO2000025814A2 Component for vaccine against serogroup b meningococci |
| 05/11/2000 | WO2000025812A2 Method for preparing solid phase conjugate vaccines |
| 05/11/2000 | WO2000025811A2 Multicomponent meningococcal vaccine |
| 05/11/2000 | WO2000025808A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 05/11/2000 | WO2000025799A1 β-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HIV INFECTION |
| 05/11/2000 | WO2000025797A1 Combination therapy to treat hepatitis b virus |